Advertisement Lannett introduces FDA approved drugs - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lannett introduces FDA approved drugs

Lannett Company has launched three products including Diethylpropion Tablets 25mg, Phentermine HCI Capsules 37.5mg and Loxapine Capsules 5 mg, 10 mg, 25 mg and 50 mg, which have been approved by the US Food and Drug Administration (FDA).

According to the company, the sales of these products would strengthen their product offering and is hopeful to be a solid contributor to both sales and profits in fiscal 2012.

Lannett president and CEO Arthur P Bedrosian said the sales of the three items were in their guidance issued during the earnings call.

The company is known for developing, manufacturing, packaging, marketing and distribution of generic pharmaceutical products.